Factors of Interest in Extended-Release Buprenorphine: Comparisons Between Incarcerated and Non-Incarcerated Patients with Opioid Use Disorder

PURPOSE: Extended-release buprenorphine (XR-BUP) covers a range of formulations of buprenorphine-based treatments for opioid use disorder (OUD) that release the medication over a period of one week, one month, or six months. OUD is particularly prevalent among incarcerated populations, and previous...

Descripción completa

Detalles Bibliográficos
Autores principales: Chappuy, Mathieu, Meroueh, Fadi, Trojak, Benoit, Bachellier, Jérôme, Bendimerad, Patrick, Kosim, Margaux, Hjelmström, Peter, Nubukpo, Philippe, Brousse, Georges, Rolland, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214559/
https://www.ncbi.nlm.nih.gov/pubmed/34163143
http://dx.doi.org/10.2147/PPA.S311674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214559/
https://www.ncbi.nlm.nih.gov/pubmed/34163143
http://dx.doi.org/10.2147/PPA.S311674

Ejemplares similares